Determination of Changes in Blood Biomarker Levels in Antipsychotic Polypharmacy and Aripiprazole Monotherapy in Patients With Long-term Schizophrenia
Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Objectives

Schizophrenia is a chronic psychiatric disorder, which reduces the patient’s quality of life. Although a minimum dose of medications has been recommended for treating this disorder, antipsychotic polypharmacy has been used experimentally leading to an increase in drug interactions. Aripiprazole is associated with a lower risk of metabolic side effects and is recommended as a first-line treatment for schizophrenia. Biomarkers can serve as predictive of treatment response in patients with schizophrenia. The aim of this study was to compare the efficacy of antipsychotic medication polypharmacy with Aripiprazole monotherapy in patients with long-term schizophrenia, using blood biomarkers.

Methods

Nineteen patients with long-term schizophrenia, who had received at least 2 types of antipsychotics with daily doses of more than 500 mg of chlorpromazine, were included in the study. The response rates to the treatment based on the Brief Psychiatric Rating Scale (BPRS) score and the blood level of Interleukin 2 (IL-2), Interleukin 6 (IL-6), Interleukin-1 Receptor Antagonist (IL-1RA), and Brain-derived Neurotrophic Factor (BDNF) biomarkers were compared in antipsychotic polypharmacy and 6 months after monotherapy with Aripiprazole.

Results

The mean concentrations of IL-6, IL-1RA, and IL-2 significantly decreased after the intervention. The mean changes in the BPRS scores and also the relationship between changes in blood biomarkers and BPRS scores after intervention were not significant.

Discussion

The conversion of the antipsychotic polypharmacy state to monotherapy with Aripiprazole has been accompanied by a significant decrease in the serum levels of IL-2, IL-6, and IL-1RA. These biomarkers can be used for evaluating the response rate of schizophrenia treatments in the future.

Language:
English
Published:
Iranian Rehabilitation Journal, Volume:17 Issue: 42, Dec 2019
Pages:
369 to 376
magiran.com/p2134030  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 990,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 50 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!